ResMed, Inc. (RMD) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $228.42 +0.07%
Revenue Growth %: +6.9%
Financial Fact:
Gross profit: 269.18M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +6.9%
Financial Fact:
Gross profit: 269.18M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.63, $0.01 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $397.8 million versus the consensus estimate of $401 million.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- AM Best Revises Outlooks to Positive for Triangle Insurance Company
- Astrana Health (ASTH) Mentioned as short at Glass House
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
